| 中文名称: | 阿拉氯胺 | ||||
|---|---|---|---|---|---|
| 英文名称: | Alagebrium chloride | ||||
| 别名: | 4,5-二甲基-3-(2-氧代-2-苯乙基)噻唑氯化物 ALT711;4,5-Dimethyl-3-(2-oxo-2-phenylethyl)thiazolium Chloride | ||||
| CAS No: | 341028-37-3 | 分子式: | C13H14ClNOs | 分子量: | 267.77 |
| CAS No: | 341028-37-3 | ||||
| 分子式: | C13H14ClNOs | ||||
| 分子量: | 267.77 | ||||
包装规格：
250mg 1g 5g in glass bottle
溶解性：
溶于DMSO（≥25mg/mL）
产品描述：
一种晚期糖基化终产物 (AGE) 抑制剂。
Alagebrium Chloride, also known as ALT711, was a drug candidate developed by Alteon, Inc. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts (AGEs), thereby reversing one of the main mechanisms of aging. Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking. Alagebrium has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic
Alagebrium Chloride, also known as ALT711, was a drug candidate developed by Alteon, Inc. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts (AGEs), thereby reversing one of the main mechanisms of aging. Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking. Alagebrium has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic
保存条件：
室温 充氮保存
UN码：
HazardClass：
危害声明：
安全说明：
搜索质检报告(COA)
参考文献 & 客户发表文献
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液，使用的计算公式为：
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为：C1V1 = C2V2 ( 输入 输出 )
